Quanterix (QTRX) Cash from Financing Activities (2017 - 2026)
Quanterix (QTRX) posted Cash from Financing Activities of -$770000.0 for Q1 2026, down 47.51% on a QoQ basis from -$522000.0 in Q4 2025, and down 927.96% year-over-year from $93000.0 in Q1 2025.
Quanterix (QTRX) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Quanterix's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at -$770000.0 for Q1 2026.
- Quarterly Cash from Financing Activities fell 927.96% year-over-year to -$770000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 3042.0% YoY) and the FY2025 annual result came in at -$708000.0, down 255.26% from the prior year.
- Cash from Financing Activities was -$770000.0 for Q1 2026 at Quanterix, down from -$522000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.8 million in Q3 2023 and bottomed at -$770000.0 in Q1 2026.
- A 5-year average of $234117.6 and a median of $150000.0 in 2025 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities surged 342.26% — and 2025, when it sank 1373.17%.
- Quanterix's Cash from Financing Activities stood at $714000.0 in 2022, then tumbled by 71.85% to $201000.0 in 2023, then slumped by 79.6% to $41000.0 in 2024, then sank by 1373.17% to -$522000.0 in 2025, then plunged by 47.51% to -$770000.0 in 2026.
- Business Quant data shows QTRX's Cash from Financing Activities at -$770000.0 in Q1 2026, -$522000.0 in Q4 2025, and $150000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | -770,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -770,000.00 |
| Mar 31, 2026 | -770,000.00 |
| Dec 31, 2025 | -522,000.00 |
| Dec 31, 2025 | -522,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | -429,000.00 |
| Jun 30, 2025 | -429,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | -328,000.00 |
| Jun 30, 2024 | -328,000.00 |
| Mar 31, 2024 | 599,000.00 |
| Mar 31, 2024 | 599,000.00 |
| Dec 31, 2023 | 201,000.00 |
| Dec 31, 2023 | 201,000.00 |